<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-House" bill-type="olc" dms-id="HAC26D56268014C93AF83395CCA69B6EA" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 1922 RH: Restoring Access to Medication Act of 2019</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2020-12-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">IB</distribution-code><calendar display="yes">Union Calendar No. 559</calendar><congress display="yes">116th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 1922</legis-num><associated-doc role="report" display="yes">[Report No. 116–675]</associated-doc><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20190327">March 27, 2019</action-date><action-desc><sponsor name-id="K000188">Mr. Kind</sponsor> (for himself, <cosponsor name-id="M001188">Ms. Meng</cosponsor>, <cosponsor name-id="W000813">Mrs. Walorski</cosponsor>, and <cosponsor name-id="L000585">Mr. LaHood</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name></action-desc></action><action display="yes"><action-date date="20201218">December 18, 2020</action-date><action-desc>Additional sponsors: <cosponsor name-id="F000466">Mr. Fitzpatrick</cosponsor>, <cosponsor name-id="D000191">Mr. DeFazio</cosponsor>, <cosponsor name-id="G000581">Mr. Gonzalez of Texas</cosponsor>, <cosponsor name-id="B001285">Ms. Brownley of California</cosponsor>, <cosponsor name-id="A000378">Mrs. Axne</cosponsor>, <cosponsor name-id="R000616">Mr. Rouda</cosponsor>, <cosponsor name-id="W000826">Ms. Wild</cosponsor>, <cosponsor name-id="K000376">Mr. Kelly of Pennsylvania</cosponsor>, <cosponsor name-id="S001172">Mr. Smith of Nebraska</cosponsor>, and <cosponsor name-id="D000631">Ms. Dean</cosponsor></action-desc><action-desc></action-desc></action><action display="yes"><action-date date="20201218">December 18, 2020</action-date><action-desc>Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed</action-desc><action-instruction>Strike out all after the enacting clause and insert the part printed in italic</action-instruction><action-instruction>For text of introduced bill, see copy of bill as introduced on March 27, 2019</action-instruction><action-desc><pagebreak></pagebreak></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Internal Revenue Code of 1986 to include certain over-the-counter medical products as qualified medical expenses.<pagebreak></pagebreak></official-title></form><legis-body display-enacting-clause="yes-display-enacting-clause" changed="added" style="OLC" committee-id="HWM00" reported-display-style="italic" id="H9BF90B6615454BE08C86B4E637414ED5"><section id="H7A608F1F9B3341C49DAD8E3963381899" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Restoring Access to Medication Act of 2019</short-title></quote>.</text></section><section display-inline="no-display-inline" id="H58E18D1FD91C4C18A8E902F63A844EBB"><enum>2.</enum><header>Inclusion of certain over-the-counter medical products as qualified medical expenses</header><subsection id="HA03DED4EB636445A8B20013518169A3F"><enum>(a)</enum><header>HSAs</header><text display-inline="yes-display-inline"><external-xref legal-doc="usc" parsable-cite="usc/26/223">Section 223(d)(2)</external-xref> of the Internal Revenue Code of 1986 is amended—</text><paragraph id="HF86EA5316F0F49089464CFF2B5E69FF2"><enum>(1)</enum><text>by striking the last sentence of subparagraph (A) and inserting the following: <quote>For purposes of this subparagraph, amounts paid for menstrual care products shall be treated as paid for medical care.</quote>; and</text></paragraph><paragraph id="H1CD51382AFD741858894CB6BA6CDD5CC"><enum>(2)</enum><text>by adding at the end the following new subparagraph:</text><quoted-block display-inline="no-display-inline" id="H0244077BA4DF4094AF23AFB749F230DB" style="OLC" changed="added" reported-display-style="italic" committee-id="HWM00"><subparagraph id="H40D30AEB7C9941AA982981A4C0FB1CC3"><enum>(D)</enum><header>Menstrual care product</header><text>For purposes of this paragraph, the term <quote>menstrual care product</quote> means a tampon, pad, liner, cup, sponge, or similar product used by individuals with respect to menstruation or other genital-tract secretions.</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="H38990F1D257C4FFF9D25BBF45AAA6DEF"><enum>(b)</enum><header>Archer MSAs</header><text display-inline="yes-display-inline">Section 220(d)(2)(A) of such Code is amended by striking the last sentence and inserting the following: <quote>For purposes of this subparagraph, amounts paid for menstrual care products (as defined in section 223(d)(2)(D)) shall be treated as paid for medical care.</quote>.</text></subsection><subsection id="HCCE99833DFC6424EA3DC122080C49349"><enum>(c)</enum><header>Health flexible spending arrangements and health reimbursement arrangements</header><text display-inline="yes-display-inline">Section 106 of such Code is amended by striking subsection (f) and inserting the following new subsection:</text><quoted-block display-inline="no-display-inline" id="H8849BC3F9AD54BBDAA03E3FBAC307E02" style="OLC" changed="added" reported-display-style="italic" committee-id="HWM00"><subsection id="H4E9135482AD34BF8855A34C0E76B0BBE"><enum>(f)</enum><header>Reimbursements for menstrual care products</header><text display-inline="yes-display-inline">For purposes of this section and section 105, expenses incurred for menstrual care products (as defined in section 223(d)(2)(D)) shall be treated as incurred for medical care.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HAF165B12E81C4E99B1B43CFC7D4DACE3"><enum>(d)</enum><header>Effective dates</header><paragraph id="H4835671866B54146A2F19DEBBF89B9DD"><enum>(1)</enum><header>Distributions from savings accounts</header><text>The amendments made by subsections (a) and (b) shall apply to amounts paid after December 31, 2019.</text></paragraph><paragraph id="HCDE0D51C316E4C0D840E8F80D6A3506B"><enum>(2)</enum><header>Reimbursements</header><text>The amendment made by subsection (c) shall apply to expenses incurred after December 31, 2019.</text></paragraph></subsection></section></legis-body><endorsement display="yes"><action-date>December 18, 2020</action-date><action-desc>Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed</action-desc></endorsement></bill> 

